Related Experiment Video
Updated: Jun 10, 2026

Trace Fear Conditioning in Mice
Published on: March 20, 2014
Memory for fear extinction requires mGluR5-mediated activation of infralimbic neurons
Darah E Fontanez-Nuin1, Edwin Santini, Gregory J Quirk
1Department of Physiology and Pharmacology, Ponce School of Medicine, Ponce, Puerto Rico 00732-7004.
Abstract:
Consolidation of fear extinction involves enhancement of N-methyl D aspartate (NMDA) receptor-dependent bursting in the infralimbic region (IL) of the medial prefrontal cortex (mPFC). Previous studies have shown that systemic blockade of metabotropic glutamate receptor type 5 (mGluR5) reduces bursting in the mPFC and mGluR5 agonists enhance NMDA receptor currents in vitro, suggesting that mGluR5 activation in IL may contribute to fear extinction. In the current study, rats injected with the mGluR5 antagonist 2-methyl-6-(phenylethyl)-pyridine (MPEP) systemically, or intra-IL, prior to extinction exhibited normal within-session extinction, but were impaired in their ability to recall extinction the following day. To directly determine whether mGluR5 stimulation enhances the burst firing of IL neurons, we used patch-clamp electrophysiology in prefrontal slices. The mGluR5 agonist, (RS)-2-chloro-5-hydroxyphenylglycine (CHPG), increased intrinsic bursting in IL neurons. Increased bursting was correlated with a reduction in the slow after hyperpolarizing potential and was prevented by coapplication of MPEP. CHPG did not increase NMDA currents, suggesting that an NMDA receptor-independent enhancement of IL bursting via stimulation of mGluR5 receptors contributes to fear extinction. Therefore, the mGluR5 receptor could be a suitable target for pharmacological adjuncts to extinction-based therapies for anxiety disorders.
Insights
Metabotropic glutamate receptor type 5 (mGluR5) activation in the infralimbic cortex enhances fear extinction memory recall. Targeting mGluR5 may offer new treatments for anxiety disorders.
Area of Science:
- Neuroscience
- Behavioral Neuroscience
- Pharmacology
Background:
- Fear extinction memory consolidation involves N-methyl D-aspartate (NMDA) receptor-dependent bursting in the medial prefrontal cortex (mPFC).
- Metabotropic glutamate receptor type 5 (mGluR5) antagonists reduce mPFC bursting, while agonists enhance NMDA receptor currents, suggesting a role for mGluR5 in fear extinction.
Purpose of the Study:
- To investigate the role of mGluR5 stimulation in the infralimbic (IL) region of the mPFC in fear extinction recall.
- To determine if mGluR5 activation directly enhances burst firing in IL neurons.
Main Methods:
- Rats received systemic or intra-IL injections of an mGluR5 antagonist (MPEP) before extinction training.
- Patch-clamp electrophysiology was used in prefrontal slices to examine the effects of an mGluR5 agonist (CHPG) on IL neuronal bursting.
- Effects of CHPG on NMDA currents were also assessed.
Main Results:
- Systemic or intra-IL MPEP administration impaired fear extinction recall the following day, despite normal within-session extinction.
- The mGluR5 agonist CHPG increased intrinsic bursting in IL neurons, which correlated with a reduced slow afterhyperpolarization.
- CHPG-induced bursting was blocked by MPEP and did not involve potentiation of NMDA receptor currents.
Conclusions:
- mGluR5 stimulation enhances IL neuronal bursting independently of NMDA receptor potentiation, contributing to fear extinction recall.
- The mGluR5 receptor represents a potential therapeutic target for enhancing extinction-based treatments for anxiety disorders.
Related Concept Videos
Role of Amygdala in Memory
One of the...
Functional Brain Systems: Limbic System
Role of Cerebellum and Prefrontal Cortex in Memory

